From the Journals

Want to keep cancer patients and providers safe during the pandemic? Here’s how


 

FROM THE JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

With careful review and some changes, cancer centers can provide effective care during the COVID-19 pandemic without sacrificing the safety of patients, caregivers, and health care workers, according to the authors of a special feature article in the Journal of the National Comprehensive Cancer Network.

Pelin Cinar, MD, of the University of California San Francisco Hellen Diller Family Comprehensive Cancer Center

Dr. Pelin Cinar

Prescreening, telemedicine, and limiting procedures top the authors’ list of 10 recommendations for ensuring patient safety in U.S. oncology practices. Assuring appropriate personal proctective equipment (PPE), encouraging telecommuting, and providing wellness/stress management are a few of the ways to look out for health care worker safety during the crisis.

These recommendations were drafted to provide guidance during the rapidly evolving global pandemic that, in some cases, has deluged health care delivery systems and strained the ability of providers to assure safe and effective care, said lead author Pelin Cinar, MD, of the Hellen Diller Family Comprehensive Cancer Center at the University of California, San Francisco.

“I think we have been so overwhelmed that sometimes it’s difficult to get organized in our thought processes,” Dr. Cinar said in an interview. “So this [article] was really trying to provide some structure to each of the different steps that we should be addressing at minimum.”

Screening patients

Prescreening systems are a critical first step to ensure cancer centers are helping control community spread of the virus, according to the article. Whether done by phone or online, prescreening 1-2 days before a patient’s visit can help identify COVID-19 symptoms and exposure history, guiding whether patients need to be evaluated, monitored, or referred to an ED.

Next, screening clinics can help ensure cancer patients with COVID-19 symptoms are evaluated and tested in a unit with dedicated staff, according to the article.

“If symptomatic patients present to the cancer center for treatment after a negative prescreening assessment, they must be provided with a mask and directed to a screening clinic for evaluation and potential testing before moving forward with any cancer-directed therapy,” the article states.

Telemedicine and treatment

Telemedicine visits should be done whenever possible to avoid in-person visits, according to the article. Dr. Cinar said that her center, like other cancer centers, has seen a major uptick in these visits, which are typically done over video. In February, there were a total of 232 video visits at her center, which jumped to 1,702 in March, or an approximate 600% increase.

“Even though we had a relatively robust presence [before the pandemic], we still weren’t at a level where we are now,” Dr. Cinar said.

When it comes to cancer treatment, surgeries and procedures should be limited to essential or urgent cases, and, if possible, chemotherapy and systemic therapy regimens can be modified to allow for fewer visits to the cancer center or infusion center, according to the article.

Transitions to outpatient care can help further reduce the need for in-person visits, while intervals between scans can be increased, or biochemical markers can be used instead of scans.

Pages

Recommended Reading

Cautionary tale spurs ‘world’s first’ COVID-19 psychiatric ward
MDedge Hematology and Oncology
How to sanitize N95 masks for reuse: NIH study
MDedge Hematology and Oncology
Infectious disease experts say testing is key to reopening
MDedge Hematology and Oncology
N.Y. universal testing: Many COVID-19+ pregnant women are asymptomatic
MDedge Hematology and Oncology
2019-2020 flu season ends with ‘very high’ activity in New Jersey
MDedge Hematology and Oncology
In praise of parents and children
MDedge Hematology and Oncology
Almost half of med practices furloughing staff, one-fifth have layoffs
MDedge Hematology and Oncology
Switching gears at high speed
MDedge Hematology and Oncology
Flexibility and speed mark the race to a COVID-19 vaccine
MDedge Hematology and Oncology
ESMO outlines priorities for GI cancer treatment in the COVID-19 era
MDedge Hematology and Oncology